Results 71 to 80 of about 6,879 (152)

Clopidogrel-Induced Neutropenia after Coronary Stenting: Is Cilostazol a Good Alternative?

International Journal of Vascular Medicine, 2011
Dual antiplatelet therapy with aspirin plus thienopyridines has become the standard treatment of patients undergoing coronary stenting. Clopidogrel has mostly replaced the use of ticlopidine due to its more favourable adverse event profile. However, also
Massimo Montalto, Italo Porto, Antonella Gallo, Claudia Camaioni, Roberta Della Bona, Antonio Grieco, Filippo Crea, Raffaele Landolfi   +7 more
doaj   +1 more source

Aortic thrombus in a patient with myeloproliferative thrombocytosis, successfully treated by pharmaceutical therapy: a case report

Journal of Medical Case Reports, 2010
Introduction Thrombosis in myeloproliferative thrombocytosis occurs usually in the microvessels and medium-sized arteries and veins and only rarely in the aorta. Aortic thrombosis is usually treated with thrombectomy.
Imai Norikazu, Nishimaki Haruaki, Yamamoto Hidesuke, Nitta Masakazu, Daimaru Osami   +4 more
doaj   +1 more source

Analysis of the structure of consumption of antiplatelet drugs in the Russian pharmaceutical market: 2014-2016

Качественная клиническая практика, 2018
This article analyzes the volume of the Russian pharmaceutical market of antiplatelet drugs in the period 2014-2016. 80% of patients take clopidogrel generics, giving preference to Zilt®.
S. K. Zyryanov, E. V. Dumchenko
doaj  

Current Concepts on Antiplatelet Therapy: Focus on the Novel Thienopyridine and Non-Thienopyridine Agents

Advances in Hematology, 2010
Thienopyridines are a class of drug targeting the platelet adenosine diphosphate (ADP) 2 receptor. They significantly reduce platelet activity and are therefore clinically beneficial in settings where platelet activation is a key pathophysiological ...
L. Testa, G. G. L. Biondi Zoccai, M. Valgimigli, R. A. Latini, S. Pizzocri, S. Lanotte, M. L. Laudisa, N. Brambilla, M. R. Ward, G. A. Figtree, F. Bedogni, R. Bhindi   +11 more
doaj   +1 more source

Influence of methadone on clopidogrel in addicts on methadone maintenance therapy

Caspian Journal of Internal Medicine, 2016
Background: Clopidogrel is a prodrug that converts in the liver to an active thiol metabolite, which irreversibly inhibits the platelet P2Y12 adenosine diphosphate receptor.
Ferigol Fallah, Abolhasan Hamidikenari, Seyed Navid Sajadi, Seyed Rohollah Sajadi, Mohammad Reza Shiran   +4 more
doaj  

Cerebral DWI lesion burden following carotid artery stenting with guided antiplatelet therapy: a retrospective comparative study. [PDF]

CVIR Endovasc
Vigláš P, Raupach J, Hejčl A, Černík D, Hrach K, Matras P, Bradáčová P, Ryška P, Cihlář F.   +8 more
europepmc   +1 more source

Kaposiform hemangioendothelioma associated with coagulopathy and treated with low-dose aspirin - A three-case series. [PDF]

An Bras Dermatol
Pereira LB, Magalhães GM, Ribeiro DD, Garcia MM, Marques KB, Gontijo JRV.   +5 more
europepmc   +1 more source

Prevalence of Potentially Inappropriate Medications in Drug Dispensing Data of Older Adults Living in Northwest Italy. [PDF]

Pharmacy (Basel)
Armando LG, Luboz J, Diarassouba A, Miglio G, Cena C.   +4 more
europepmc   +1 more source

Creation of a Merged Harmonized Large Database of Subject-Level Data from Acute Secondary Prevention Studies in Minor Non-Cardioembolic Stroke or TIA. [PDF]

Int J Cerebrovasc Dis Stroke
Brorson JR, Beniwal S, Giurcanu M, Landron D, Landron S, Siegler JE, Prabhakaran S, Johnson JA.   +7 more
europepmc   +1 more source

Synergistic effects of anticoagulants and platelet aggregation inhibitors with immune checkpoint inhibitors in cancer therapy: a comprehensive review of preclinical and clinical evidence. [PDF]

J Immunother Cancer
Kött J, Matthes N, Bauer AT, Zimmermann N, Zell T, Smit DJ, Schneider SW, Gebhardt C.   +7 more
europepmc   +1 more source